We focus on Essential Drugs.
- Critical Care
- Emergency Care
- Rare Diseases
- Metabolic Disorders
SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.
Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.
Our commitment is to continue to offer essential drugs meeting Public Health needs.
Our therapeutic areas
SERB benefits from a portfolio of specialty products in
Critical Care and Rare Diseases
SERB has recently strengthened its Neurology and Rare Diseases franchise
with the acquisition of Veriton pharma
SERB has consolidated a global leading position in
Emergency Care: wide range of lifesaving medical countermeasures and intensive care medicines
Surgery: drugs and devices for supportive care as well as diagnostic agents
SERB has extended its portfolio into the treatment of
Neurology: treatments for rare and severe epileptic and neuromuscular conditions
Metabolic disorders: medicines for paediatric inborn errors of metabolism
An international presence
SERB Specialty Pharmaceuticals is global pharmaceutical group with a direct presence in Europe, in the Middle East and Australia, and over 80 countries including the US and Japan through a broad network of experienced distributors.
Avenue Louise 480
8 rue Beaumont
Eagle Court, 9 Vine Street, Uxbridge
Middlesex, UB8 1 QE
Veriton Pharma Ltd
Unit 16, Trade City,
Avro Way, Weybridge
Surrey, KT13 0YF
40 Avenue George V
SERB SP. ZO.O.
Pl. Pilsudkiego 1,
United Arab Emirates
Veriton MEA FZCo
Building 3W, Office 210
DAFZA PO Box 293727